Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Infectious: Page 3
POC test offers low-cost way to screen for toxoplasmosis during pregnancy
By
Liz Carey
Gestational screening programs might benefit from a new clinical laboratory point-of-care (POC) diagnostic test that hunts for a parasite that can be transmitted during pregnancy.
May 29, 2024
GMU researchers receive $1.2M in funding for Lyme disease urine test
By
LabPulse.com staff writers
Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.
May 24, 2024
University of Florida researchers develop CRISPR-based assay for HPV detection
By
LabPulse.com staff writers
Researchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.
May 7, 2024
Scout secures CARB-X grant to advance diagnostic test development
By
LabPulse.com staff writers
Scout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.
April 22, 2024
Researchers tweak TB treatment assay to support global use
By
Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
WHO launches new guidance on TB diagnostics
By
LabPulse.com staff writers
The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.
March 21, 2024
Harvard team develops compound to combat drug-resistant bacteria
By
Matt Limb
Harvard University researchers say they have created an antibiotic that can overcome many drug-resistant infections.
March 13, 2024
New class of broad-spectrum antivirals could be first line of pandemic defense: Study
By
Nick Paul Taylor
Targeting a cellular pathway has inhibited SARS-CoV-2 and other RNA viruses in preclinical tests, pointing to a potential new class of first-line antivirals with broad effectiveness against emerging pathogens.
March 5, 2024
BioMérieux, FDA to collaborate on combating food-borne pathogens
By
LabPulse.com staff writers
BioMérieux has entered into a strategic research collaboration with the U.S. Food and Drug Administration (FDA) to develop technologies to improve the detection and characterization of food-borne pathogens.
March 1, 2024
Global research network launches to fight strep A infections
By
Matt Limb
Scientists have launched a global research network to combat deadly strep A infections that can trigger sepsis and heart damage in children.
February 27, 2024
Bavarian Nordic ends cancer vaccine program
By
LabPulse.com staff writers
Biotech firm Bavarian Nordic is ceasing all work on its cancer vaccine program, instead prioritizing its infectious disease projects.
February 22, 2024
Previous Page
Page 3 of 152
Next Page